Related Experiment Video
Updated: Jul 19, 2025

06:20
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
Published on: December 24, 2015
12.3K
Mesenchymal Stromal Cell Secretome Is Affected by Tissue Source and Donor Age
Agnieszka J Turlo1, Dean E Hammond2, Kerry A Ramsbottom3
1Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Stem Cells (Dayton, Ohio)
|August 17, 2023
Summary
Mesenchymal stromal cell (MSC) secretome varies by tissue source and donor age. These factors influence the protein composition of MSCs, impacting potential therapeutic outcomes in equine treatments.
Area of Science:
- Veterinary Medicine
- Cell Biology
- Proteomics
Background:
- Mesenchymal stromal cells (MSCs) show variable function based on origin, potentially affecting therapy outcomes.
- Therapeutic benefits of MSCs are linked to their secreted factors (secretome).
- The impact of donor characteristics on the MSC secretome is not well understood.
Purpose of the Study:
- To investigate how donor age, sex, and tissue source influence the protein profile of equine MSC secretomes.
- To identify specific proteins affected by these donor characteristics.
Main Methods:
- Utilized dynamic metabolic labeling with stable isotopes and liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify secreted proteins.
- Analyzed conditioned media from bone marrow- and adipose-derived MSCs using label-free LC-MS/MS.
- Applied clustering and linear modeling to analyze proteomic data.
Main Results:
- Identified 70 classically secreted proteins and 314 total proteins across samples.
- Tissue source was the primary driver of variability in MSC secretomes.
- Tissue source differences were observed in 23 secreted proteins; donor age correlated with decreased CTHRC1 and LOX abundance.
Conclusions:
- Equine MSC secretome composition is significantly influenced by tissue source and donor age.
- These variations may impact the efficacy and clinical outcomes of MSC-based therapies.
- Further research is needed to understand the implications of cell population heterogeneity.

